Imidazole → 2-(4-Imidazol-1-yl-2-methoxy-phenyl)-5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazole

HRID 1983113Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 1983113
F[C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][C:10]([C:13]3[C:14]([C:19]4[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=4)=[N:15][O:16][C:17]=3[CH3:18])=[N:11][N:12]=2)=[C:4]([O:25][CH3:26])[CH:3]=1.[NH:27]1[CH:31]=[CH:30][N:29]=[CH:28]1>>[N:27]1([C:2]2[CH:7]=[CH:6][C:5]([C:8]3[O:9][C:10]([C:13]4[C:14]([C:19]5[CH:24]=[CH:23][CH:22]=[CH:21][CH:20]=5)=[N:15][O:16][C:17]=4[CH3:18])=[N:11][N:12]=3)=[C:4]([O:25][CH3:26])[CH:3]=2)[CH:31]=[CH:30][N:29]=[CH:28]1

Komponenten

3

Versuchsvorschrift

As described for example 26, 2-(4-fluoro-2-methoxy-phenyl)-5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazole (200 mg, 0.57 mmol) was converted using imidazole instead of thiomorpholine to the title compound (SiO2, heptane:ethyl acetate:dichloromethane=70:10:20 to 40:40:20, 82 mg, 36%) which was obtained as an off-white solid. MS: m/e=400.2 [M+H]+.

Quellen und Nachweise

ORD-Eintrag
ord-bd61e7ab8a4c43e8afe503f48f070a67
Quelldatensatz
uspto-grants-2009_06
Patentnummer
US07541372B2

Notizen zur Reaktion

Wird geladen…